Skip to content

Clinical trials

Phase 4 Insulin Resistance trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulin Resistance Phase: Phase 4 Country / region: United States Clear all

99 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20037
20047
200511
20068
20077
20083
20096
20103
20119
20124
20134
20143
20154
20161
20172
20186
20191
20211
20223
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed72
Terminated13
Withdrawn5
Recruiting4
Unknown status4
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital4
Stanford University4
Mannkind Corporation3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)3
Northwestern University3
University of Colorado, Denver3
University of Michigan3
University of Texas Southwestern Medical Center3
Veterans Medical Research Foundation3
Virginia Commonwealth University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulin Resistance99
Diabetes Mellitus32
Diabetes Mellitus, Type 227
Metabolic Syndrome16
Obesity12
Glucose Intolerance9
Diabetes Mellitus, Type 18
Inflammation8
Schizophrenia8
Hyperglycemia5

Trials

Showing 1 to 25 of 99. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.